FI962769A - (E)-2'-deoksi-2'(fluorimetyleeni)sytidiinin monohydraatti - Google Patents

(E)-2'-deoksi-2'(fluorimetyleeni)sytidiinin monohydraatti Download PDF

Info

Publication number
FI962769A
FI962769A FI962769A FI962769A FI962769A FI 962769 A FI962769 A FI 962769A FI 962769 A FI962769 A FI 962769A FI 962769 A FI962769 A FI 962769A FI 962769 A FI962769 A FI 962769A
Authority
FI
Finland
Prior art keywords
fluoromethylene
cytidinmonohydrat
deoxi
cytidine
deoxy
Prior art date
Application number
FI962769A
Other languages
English (en)
Swedish (sv)
Other versions
FI114396B (fi
FI962769A0 (fi
Inventor
Richard Eugene Donaldson
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI962769A0 publication Critical patent/FI962769A0/fi
Publication of FI962769A publication Critical patent/FI962769A/fi
Application granted granted Critical
Publication of FI114396B publication Critical patent/FI114396B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI962769A 1994-01-07 1996-07-05 Menetelmä (E)-2'-deoksi-2'-(fluorimetyleeni)sytidiininmonohydraatin valmistamiseksi FI114396B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17895294A 1994-01-07 1994-01-07
US17895294 1994-01-07
US9414648 1994-12-13
PCT/US1994/014648 WO1995018815A1 (en) 1994-01-07 1994-12-13 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine

Publications (3)

Publication Number Publication Date
FI962769A0 FI962769A0 (fi) 1996-07-05
FI962769A true FI962769A (fi) 1996-07-05
FI114396B FI114396B (fi) 2004-10-15

Family

ID=22654587

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962769A FI114396B (fi) 1994-01-07 1996-07-05 Menetelmä (E)-2'-deoksi-2'-(fluorimetyleeni)sytidiininmonohydraatin valmistamiseksi

Country Status (20)

Country Link
EP (1) EP0738273B1 (fi)
JP (1) JPH09511227A (fi)
KR (1) KR100330328B1 (fi)
CN (1) CN1043231C (fi)
AT (1) ATE186732T1 (fi)
AU (1) AU684604B2 (fi)
CA (1) CA2179987C (fi)
DE (1) DE69421721T2 (fi)
DK (1) DK0738273T3 (fi)
ES (1) ES2141330T3 (fi)
FI (1) FI114396B (fi)
GR (1) GR3032614T3 (fi)
HU (1) HU217849B (fi)
IL (1) IL112242A (fi)
MX (1) MX9500363A (fi)
NO (1) NO306409B1 (fi)
NZ (1) NZ279030A (fi)
TW (1) TW397838B (fi)
WO (1) WO1995018815A1 (fi)
ZA (1) ZA9512B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1043324B1 (en) 1997-11-12 2004-06-16 Mitsubishi Chemical Corporation Purine derivatives and medicine containing the same as the active ingredient
KR100747106B1 (ko) 1999-05-11 2007-08-08 미쯔비시 가가꾸 가부시끼가이샤 퓨린 유도체 이수화물, 이를 유효성분으로 함유하는 의약및 이의 제조 중간체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002648C (en) * 1988-11-15 2000-02-29 James R. Mccarthy 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 2’―デオキシ―2’―メチリデンシチジンの2水和物結晶
JP3265548B2 (ja) * 1992-05-12 2002-03-11 メレルファーマス−ティカルズ インコーポレイテッド リボヌクレオチド還元酵素阻害剤の製法

Also Published As

Publication number Publication date
GR3032614T3 (en) 2000-05-31
TW397838B (en) 2000-07-11
NZ279030A (en) 1997-05-26
DE69421721D1 (de) 1999-12-23
IL112242A (en) 2000-08-31
HUT75055A (en) 1997-03-28
WO1995018815A1 (en) 1995-07-13
CA2179987C (en) 1999-01-19
DE69421721T2 (de) 2000-04-27
AU684604B2 (en) 1997-12-18
NO306409B1 (no) 1999-11-01
IL112242A0 (en) 1995-03-30
FI114396B (fi) 2004-10-15
JPH09511227A (ja) 1997-11-11
NO962848D0 (no) 1996-07-05
HU9601848D0 (en) 1996-09-30
ES2141330T3 (es) 2000-03-16
NO962848L (no) 1996-09-06
CN1043231C (zh) 1999-05-05
FI962769A0 (fi) 1996-07-05
CN1141045A (zh) 1997-01-22
AU1553295A (en) 1995-08-01
ATE186732T1 (de) 1999-12-15
MX9500363A (es) 1998-04-30
HU217849B (hu) 2000-04-28
DK0738273T3 (da) 2000-04-17
EP0738273B1 (en) 1999-11-17
EP0738273A1 (en) 1996-10-23
ZA9512B (en) 1995-09-11
KR100330328B1 (ko) 2002-12-05
CA2179987A1 (en) 1995-07-13

Similar Documents

Publication Publication Date Title
BR9811121A (pt) Produto, composição farmacêutica, e uso de um produto
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
BRPI0411900A (pt) compostos antivirais e métodos
FI963070A0 (fi) Klooripyrimidiinivälituotteita
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
CA2002648A1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
FI962769A (fi) (E)-2'-deoksi-2'(fluorimetyleeni)sytidiinin monohydraatti
MY124071A (en) Treatment of viral disease in swine
BR9811643A (pt) Suplementação quìmica de osso
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
DK178188A (da) Antivirusmiddel
DK0459176T3 (da) Oligophosphater med antiviral virkning
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
AR015724A1 (es) La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central.
ES2085023T3 (es) Procedimientos para la produccion de zidovudina.
SE9403861D0 (sv) Novel medicinal use
BR9906931A (pt) Triazepinonas, processo para sua preparação e sua aplicação terapêutica
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
DE69407180T2 (de) Fluoro-nukleosid-reinigung
ITCA950008A0 (it) Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114396

Country of ref document: FI